Gamida Cell Ltd

(NASDAQ:GMDA)

Latest On Gamida Cell Ltd (GMDA):

Date/Time Type Description Signal Details
2023-05-22 22:17 ESTNewsGamida Cell gets new finance chiefN/A
2023-05-16 00:13 ESTNewsGamida Cell GAAP EPS of -$0.27 in-lineN/A
2023-05-16 00:13 ESTNewsGamida Cell Ltd. (GMDA) Q1 2023 Earnings Call TranscriptN/A
2023-04-28 19:53 ESTNewsGamida: The Die Is Now CastN/A
2023-04-19 11:08 ESTNewsGamida Cell stock dips after pricing $23M securities offeringN/A
2023-04-18 23:26 ESTNewsHot Stocks: BLU rises on buy out offer from GSK; ERIC slips on earnings; NVDA, GMDA gains; MP slidesN/A
2023-04-17 21:56 ESTNewsGamida cell therapy Omisirge for blood cancer patients approved by FDAN/A
2023-03-27 15:34 ESTNewsGamida Cell GAAP EPS of -$1.24 misses by $0.05N/A
2023-03-27 15:34 ESTNewsGamida Cell Ltd. (GMDA) Q4 2023 Earnings Call TranscriptN/A
2023-03-27 15:34 ESTNewsGamida Cell tanks after dismal cash runway guidance for 2023N/A
2023-03-25 02:34 ESTNewsGamida Cell FY 2022 Earnings PreviewN/A
2023-03-21 05:08 ESTNewsGamida Cell names Shawn Cline Tomasello chairwomanN/A
2022-11-22 20:48 ESTNewsGamida Cell sheds 21% as FDA extends review for lead candidateN/A
2022-11-15 02:38 ESTNewsGamida Cell Ltd. (GMDA)Q3 2022 Earnings Call TranscriptN/A
2022-11-14 09:16 ESTNewsGamida Cell GAAP EPS of -$0.29 beats by $0.02N/A
2022-11-13 17:26 ESTNewsGamida Cell Q3 2022 Earnings PreviewN/A
2022-11-07 19:18 ESTNewsGamida's rises 5% after cell therapy candidate GDA-501 shows promising antitumor activity against HER2+ cancersN/A
2022-09-30 02:22 ESTNewsGamida Cell gains on long-term data for blood cancer therapyN/A
2022-09-28 19:23 ESTNewsGamida Cell shares slide on pricing ~$20M stock offeringN/A
2022-09-28 19:23 ESTNewsGamida gets $25M debt financing commitment from Highbridge CapitalN/A
2022-09-28 03:43 ESTNewsGamida Cell shares slide after stock offeringN/A
2022-09-19 23:24 ESTNewsGamida appoints Emergent’s former head of vaccines as new CEON/A
2022-08-17 01:41 ESTNewsGamida Cell: Gearing Up For FDA ApprovalN/A
2022-08-15 15:52 ESTNewsGamida Cell GAAP EPS of -$0.31 misses by $0.02N/A
2022-08-15 15:52 ESTNewsGamida Cell Ltd. (GMDA) CEO Julian Adams on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-12 19:42 ESTNewsGamida Cell Q2 2022 Earnings PreviewN/A
2022-08-01 11:02 ESTNewsGamida stock rises 13% as FDA grants priority review to stem cell therapy omidubicelN/A
2022-06-25 02:23 ESTNewsGamida Cell (GMDA) Investor Presentation- SlideshowN/A
2022-06-03 01:58 ESTNewsGamida Cell completes rolling submission to the FDA for omidubicelN/A
2022-05-11 04:04 ESTNewsGamida Cell GAAP EPS of -$0.34 in-lineN/A
2022-05-11 04:04 ESTNewsGamida Cell Ltd. (GMDA) Management on Q1 2022 Results - Earnings Call TranscriptN/A
2022-04-27 22:51 ESTNewsGamida Cell stock falls a day after soaring on FDA lifting clinical hold on GDA-201N/A
2022-04-26 13:01 ESTNewsGamida stock soars 32% as FDA lifts hold on GDA-201, to start trial for treating blood cancerN/A
2022-03-16 01:13 ESTNewsGamida Cell GAAP EPS of -$1.52 misses by $0.10N/A
2022-03-16 01:12 ESTNewsGamida Cell Ltd. (GMDA) CEO Julian Adams on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-10 08:49 ESTNewsGamida Cell surges 22% following rolling BLA submission for omidubicelN/A
2022-02-09 12:12 ESTNewsGamida Cell begins rolling submission with FDA for omidubicel for stem cell transplantN/A
2022-01-31 17:33 ESTNewsGamida Cell provides key program updates and 2022 outlookN/A
2022-01-19 12:47 ESTNewsGamida Cell plans rolling BLA submission for omidubicel for blood cancers; shares up 18%N/A
2021-12-06 16:05 ESTNewsGamida Cell (GMDA) Investor Presentation - SlideshowN/A
2021-11-19 12:56 ESTNewsGamida Cell Ltd. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-16 01:38 ESTNewsGamida Cell EPS beats by $0.14N/A
2021-11-16 01:37 ESTNewsGamida Cell Ltd (GMDA) CEO Julian Adams on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-02 16:41 ESTNewsGamida Cell: Recapping A Tough YearN/A
2021-08-11 21:21 ESTNewsGamida Cell EPS misses by $0.36N/A
2021-08-11 21:18 ESTNewsGamida Cell Ltd. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-11 21:18 ESTNewsGamida Cell Ltd (GMDA) CEO Julian Adams on Q2 2021 Results - Earnings Call TranscriptN/A
2021-04-15 20:11 ESTNewsGamida Cell (GMDA) Presents At 20th Annual Needham Virtual Healthcare Conference - SlideshowN/A
2021-03-11 15:42 ESTFinancialsCompany financials have been released.Neutral
2021-03-11 11:41 ESTAnalyst RatingThe Analyst Target Price has increased from $18.67 to $19.Buy

About Gamida Cell Ltd (GMDA):

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that is in Phase III studies in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was founded in 1998 and is headquartered in Jerusalem, Israel.

GMDA Quotes by TradingView

See Advanced Chart

General

  • Name Gamida Cell Ltd
  • Symbol GMDA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 110
  • Fiscal Year EndDecember
  • IPO Date2018-10-26
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.gamida-cell.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 5.23
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.78
  • Next Year EPS Estimate -$1.97
  • Next Quarter EPS Estimate -$0.33
  • Return on Assets -35%
  • Return on Equity -109%
  • Earnings Per Share -$3.20
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 515.63 million
  • EBITDA -38606000
  • Analyst Target Price $19
  • Book Value Per Share $1.67
View More

Share Statistics

  • Shares Outstanding 59.2 million
  • Shares Float 41.1 million
  • % Held by Insiders 3184%
  • % Held by Institutions 33.63%
  • Shares Short 1.14 million
  • Shares Short Prior Month 1.33 million
  • Short Ratio 0.65
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 2.04
  • 52 Week High $12.47
  • 52 Week Low $2.73
  • 50 Day Moving Average 9.56
  • 200 Day Moving Average 7.32
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Gamida Cell Ltd (GMDA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Gamida Cell Ltd (GMDA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$N/A-$0.68-$0.34-98.08%
2020-09-302020-11-10$N/A-$0.30-$0.314.25%
2020-06-302020-08-11$N/A-$0.37-$0.30-24.71%
2020-03-312020-05-21$N/A-$0.31-$0.4530.8%
2019-12-312020-02-25$N/A-$0.47-$0.36-32.39%
2019-09-302019-11-13$N/A-$0.30-$0.3412.41%
2019-06-302019-08-06$N/A$0.23-$0.44152.27%
2019-03-312019-05-07$N/A-$0.62-$0.40-55%
2018-12-312019-02-25$N/A-$0.35-$0.387.97%

Gamida Cell Ltd (GMDA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Gamida Cell Ltd (GMDA) Chart:

Gamida Cell Ltd (GMDA) News:

Below you will find a list of latest news for Gamida Cell Ltd (GMDA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Gamida Cell Ltd (GMDA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-170.50.05CALL1 2480FALSE00
2024-05-1710CALL0 00FALSE00
2024-05-1720.5CALL1 10FALSE00
2024-05-1730CALL0 00FALSE00
2024-05-170.50PUT0 00TRUE00
2024-05-1710PUT0 00TRUE00
2024-05-1721.95PUT1 10TRUE00
2024-05-1733PUT2 10TRUE00
2024-06-210.50.03CALL10 5620FALSE00
2024-06-2110.1CALL20 12660FALSE00
2024-06-2120.05CALL5 1690FALSE00
2024-06-2130.1CALL250 2540FALSE00
2024-06-2140CALL0 00FALSE00
2024-06-210.50.45PUT5 50TRUE00
2024-06-2110.72PUT2 510TRUE00
2024-06-2120PUT0 00TRUE00
2024-06-2130PUT0 00TRUE00
2024-06-2140PUT0 00TRUE00
2024-09-200.50.25CALL10 130FALSE00
2024-09-2010.05CALL10 2880FALSE00
2024-09-2020CALL0 00FALSE00
2024-09-2030.1CALL0 100FALSE00
2024-09-200.50.45PUT5 8361.16TRUE00
2024-09-2010.7PUT5 390TRUE00
2024-09-2020PUT0 00TRUE00
2024-09-2030PUT0 00TRUE00
2025-01-170.50.05CALL10 3983507.17FALSE0.02-0.4
2025-01-1710.03CALL1 1650FALSE00
2025-01-171.50CALL0 00FALSE00
2025-01-1720.1CALL1 320FALSE00
2025-01-170.50.45PUT1 659299.24TRUE00
2025-01-1710.87PUT1 20TRUE00
2025-01-171.50PUT0 00TRUE00
2025-01-1720PUT0 00TRUE00
2026-01-160.50.05CALL111 56450FALSE00
2026-01-1610.1CALL10 2140FALSE00
2026-01-161.50CALL0 00FALSE00
2026-01-1620.08CALL1 150FALSE00
2026-01-1630.09CALL65 12180FALSE00
2026-01-160.50.45PUT10 734236.03TRUE00
2026-01-1610.91PUT1 20TRUE00
2026-01-161.50PUT0 00TRUE00
2026-01-1620PUT0 00TRUE00
2026-01-1630PUT0 00TRUE00

Latest GMDA Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST42$1.98
Jun 13, 2022 7:59 PM EST22$1.98
Jun 13, 2022 7:59 PM EST4$1.985
Jun 13, 2022 7:59 PM EST54$1.985
Jun 13, 2022 7:59 PM EST4$1.985

Gamida Cell Ltd (GMDA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020013408/0001213900-20-013408-index.htm
2018-06-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000018019736/0000000000-18-019736-index.htm
2018-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000018021963/0000000000-18-021963-index.htm
2018-09-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000018027851/0000000000-18-027851-index.htm
2018-10-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000018031744/0000000000-18-031744-index.htm
2019-02-25UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000019003108/0000000000-19-003108-index.htm
2019-11-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1600847/000000000019015775/0000000000-19-015775-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000031506620000975/0000315066-20-000975-index.htm
2020-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000031506620001643/0000315066-20-001643-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000090571819000211/0000905718-19-000211-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000090571820000245/0000905718-20-000245-index.htm
2018-11-08SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600847/000110465918067019/0001104659-18-067019-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000110465920020959/0001104659-20-020959-index.htm
2020-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600847/000110465920095611/0001104659-20-095611-index.htm
2018-06-01DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036118026660/0001140361-18-026660-index.htm
2018-07-03DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036118031249/0001140361-18-031249-index.htm
2018-07-03DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036118031250/0001140361-18-031250-index.htm
2018-08-24DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036118036942/0001140361-18-036942-index.htm
2018-08-24DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036118036944/0001140361-18-036944-index.htm
2018-09-28F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1600847/000114036118039574/0001140361-18-039574-index.htm
2018-09-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118039578/0001140361-18-039578-index.htm
2018-10-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118040254/0001140361-18-040254-index.htm
2018-10-17F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1600847/000114036118040749/0001140361-18-040749-index.htm
2018-10-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118040751/0001140361-18-040751-index.htm
2018-10-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118041132/0001140361-18-041132-index.htm
2018-10-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118041133/0001140361-18-041133-index.htm
2018-10-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036118041134/0001140361-18-041134-index.htm
2018-10-238-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1600847/000114036118041135/0001140361-18-041135-index.htm
2018-10-26FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1600847/000114036118041364/0001140361-18-041364-index.htm
2018-10-30424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1600847/000114036118041581/0001140361-18-041581-index.htm
2018-11-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036118042068/0001140361-18-042068-index.htm
2018-11-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600847/000114036118042831/0001140361-18-042831-index.htm
2018-11-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036118043805/0001140361-18-043805-index.htm
2019-01-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119000496/0001140361-19-000496-index.htm
2019-01-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119001569/0001140361-19-001569-index.htm
2019-02-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119002703/0001140361-19-002703-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000114036119003275/0001140361-19-003275-index.htm
2019-02-15DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000114036119003384/0001140361-19-003384-index.htm
2019-02-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119003438/0001140361-19-003438-index.htm
2019-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119003625/0001140361-19-003625-index.htm
2019-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119003721/0001140361-19-003721-index.htm
2019-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119003780/0001140361-19-003780-index.htm
2019-02-2520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1600847/000114036119003787/0001140361-19-003787-index.htm
2019-04-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000114036119006807/0001140361-19-006807-index.htm
2019-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119008107/0001140361-19-008107-index.htm
2019-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119008557/0001140361-19-008557-index.htm
2019-05-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119010144/0001140361-19-010144-index.htm
2019-06-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119010397/0001140361-19-010397-index.htm
2019-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119010449/0001140361-19-010449-index.htm
2019-06-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119010604/0001140361-19-010604-index.htm
2019-06-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119011249/0001140361-19-011249-index.htm
2019-06-24F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1600847/000114036119011438/0001140361-19-011438-index.htm
2019-06-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036119011443/0001140361-19-011443-index.htm
2019-06-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000114036119011444/0001140361-19-011444-index.htm
2019-06-26F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1600847/000114036119011535/0001140361-19-011535-index.htm
2019-06-26F-1MEFRegistration statement to add securities to prior Form F-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1600847/000114036119011725/0001140361-19-011725-index.htm
2019-06-28424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1600847/000114036119011945/0001140361-19-011945-index.htm
2019-07-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119012525/0001140361-19-012525-index.htm
2019-08-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119014449/0001140361-19-014449-index.htm
2019-09-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000114036119016530/0001140361-19-016530-index.htm
2014-03-06DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000117891314000868/0001178913-14-000868-index.htm
2014-06-12DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1600847/000117891314002038/0001178913-14-002038-index.htm
2018-11-09SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600847/000119312518323751/0001193125-18-323751-index.htm
2019-07-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600847/000119312519189228/0001193125-19-189228-index.htm
2020-05-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1600847/000119312520149860/0001193125-20-149860-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1600847/000121390019002422/0001213900-19-002422-index.htm
2019-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390019023226/0001213900-19-023226-index.htm
2019-11-14F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1600847/000121390019023541/0001213900-19-023541-index.htm
2019-11-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1600847/000121390019024600/0001213900-19-024600-index.htm
2019-12-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390019025616/0001213900-19-025616-index.htm
2020-01-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020000071/0001213900-20-000071-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020000889/0001213900-20-000889-index.htm
2020-02-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020004763/0001213900-20-004763-index.htm
2020-02-2620-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1600847/000121390020004776/0001213900-20-004776-index.htm
2020-05-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1600847/000121390020011448/0001213900-20-011448-index.htm
2020-05-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020011751/0001213900-20-011751-index.htm
2020-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020012389/0001213900-20-012389-index.htm
2020-05-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1600847/000121390020012807/0001213900-20-012807-index.htm
2020-05-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020012815/0001213900-20-012815-index.htm
2020-05-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1600847/000121390020013082/0001213900-20-013082-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020013095/0001213900-20-013095-index.htm
2020-05-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020013191/0001213900-20-013191-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020013408/0001213900-20-013408-index.htm
2020-07-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020017331/0001213900-20-017331-index.htm
2020-07-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020018044/0001213900-20-018044-index.htm
2020-08-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020020641/0001213900-20-020641-index.htm
2020-08-106-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020021158/0001213900-20-021158-index.htm
2020-08-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020021526/0001213900-20-021526-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020026019/0001213900-20-026019-index.htm
2020-09-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020026442/0001213900-20-026442-index.htm
2020-10-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020030199/0001213900-20-030199-index.htm
2020-10-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020030978/0001213900-20-030978-index.htm
2020-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020034410/0001213900-20-034410-index.htm
2020-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000121390020035176/0001213900-20-035176-index.htm
2018-10-24CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1600847/000135445718000430/0001354457-18-000430-index.htm
2019-03-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1600847/000156761919007391/0001567619-19-007391-index.htm
2018-10-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600847/999999999518002726/9999999995-18-002726-index.htm
2019-06-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600847/999999999519001454/9999999995-19-001454-index.htm
2019-11-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1600847/999999999519002687/9999999995-19-002687-index.htm
2018-10-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1600847/999999999718008816/9999999997-18-008816-index.htm